Collegium to Participate in Upcoming Investor Conferences
Rhea-AI Summary
Collegium Pharmaceutical (Nasdaq: COLL) said management will participate in two investor events in mid-April 2026: a virtual fireside chat at the 25th Annual Needham Virtual Healthcare Conference and an in-person presentation at the Piper Sandler Spring Biopharma Symposium.
The Needham fireside chat is scheduled for April 15, 2026 at 2:15 p.m. ET with a live webcast and a replay archived on the company's investor website for 90 days. Piper Sandler engagement is on April 16, 2026 in Boston.
Positive
- None.
Negative
- None.
News Market Reaction – COLL
In the Apr 8 session, COLL gained 2.05%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
STOUGHTON, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences:
25th Annual Needham Virtual Healthcare Conference
Fireside Chat Date and Time: Wednesday, April 15, 2026, at 2:15 p.m. ET
Virtual
A live webcast of the fireside chat will be available via the Investors section of the Company's website: https://ir.collegiumpharma.com. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
Piper Sandler Spring Biopharma Symposium
Thursday, April 16, 2026
Boston, MA
About Collegium Pharmaceutical, Inc.
Collegium is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a leading portfolio of responsible pain management medications and a rapidly growing neuropsychiatry business driven by Jornay PM®, a differentiated treatment for ADHD. Collegium’s strategy includes growing its commercial portfolio, with Jornay PM as the lead growth driver, and deploying capital in a disciplined manner. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Investor Contacts:
Ian Karp
Head of Investor Relations
ir@collegiumpharma.com
Danielle Jesse
Director, Investor Relations
ir@collegiumpharma.com
Media Contact:
Jessica Cotrone
Senior Vice President, Corporate Communications & Corporate Affairs
communications@collegiumpharma.com